FindTrial
Sign In

A Clinical Study To Conduct The Effect of Two Drugs Raughan-e-kahu and Raughan-e-kaddu In Patients Of Sahr (Insomnia) In Individual Of Different Temperament

To Study The Sahr (Insomnia) In Individual Of Different Temperament And Efficacy Of Raughan-e-kahu and Raughan-e-kaddu In It: A Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086674
Enrollment
80
Registered
2025-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: NIL: NIL Control Intervention1: Raughan-e-kahu: Medicine name :kahu Reference:qarabadeen majeedi Route: locally Dosage:4-6ml applied locally on scalp at night Duration:45 days Control

Sponsors

PG department of kulliyate tib
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of both sex Patient age between 20 and 50 Patient who fullfill diagnostic criteria of Insomnia (Insomnia Severity Index Scale)

Exclusion criteria

Exclusion criteria: Lesser than 20 and greater than 50 Known case of psychiatric disorders,anxiety,epilepsy,parasomnia,asthama,obstructive sleep apnea. alcohol abuse . pregnant and lactating women Patients of heart and kidney diseases veneral diseases history of trauma and head injury Patients having any malignancies

Design outcomes

Primary

MeasureTime frame
Reduction of symptoms in participants after 45 days of treatment within 3 follow-ups by given drugsTimepoint: Reduction of symptoms in participants after 45 days of treatment within 3 follow-ups by given drugs—

Secondary

MeasureTime frame
The Efficacy Of Two drugs participants overall well-being The Incidence of any adverse effects during the course of treatmentTimepoint: The Efficacy Of Two drugs participants overall well-being The Incidence of any adverse effects during the course of treatment—

Countries

India

Contacts

Public ContactDr Mohd Mahmood Farooqui

Govt nizamia tibbi college and hospital

yousufmohd96@gmail.cpm9912904786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026